232 results on '"Bewarder, Moritz"'
Search Results
2. CD16+ as predictive marker for early relapse in aggressive B-NHL/DLBCL patients
3. Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas
4. Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritis
5. T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia
6. Autoantibody-Mediated Depletion of IL-1RA in Still’s Disease and Potential Impact of IL-1 Targeting Therapies
7. Konjunktivales Mantelzelllymphom – eine therapeutische Herausforderung
8. Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma
9. Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study
10. Comparison of R‐CHOP‐14 and R‐mini‐CHOP in older adults with diffuse large B‐cell lymphoma—A retrospective multicenter cohort study.
11. KIR2DS1–HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trials
12. FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials
13. Preclinical Evaluation of a New ECCO2R Setup
14. Successful treatment of refractory donor‐specific‐human leukocyte antigen‐antibody‐induced primary graft‐failure with daratumumab: A case report.
15. Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapy
16. Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls
17. Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019
18. Renal AA amyloidosis leading to early diagnosis and treatment of takayasu arteritis: a case report and review of the literature
19. Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential
20. Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma
21. LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting
22. Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal Antibodies
23. B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma
24. B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma
25. Konjunktivales Mantelzelllymphom – eine therapeutische Herausforderung
26. Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R) - CHOP
27. Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells
28. Hyper N-Glycosylated SEL1L3 As B-Cell Receptor Autoantigen of Primary Vitreoretinal Lymphoma
29. IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination
30. Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2
31. Fewer neurocognitive deficits and less brain atrophy by third ventricle measurement in PLWH treated with modern ART: A prospective analysis
32. Comparison of immersive and non-immersive virtual reality videos as substitute for in-hospital teaching during coronavirus lockdown: a survey with graduate medical students in Germany
33. Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives
34. B‐cell receptors of EBV‐negative Burkitt lymphoma bind modified isoforms of autoantigens
35. Untersuchung des KIR-Status bei Patienten mit Plattenepithelkarzinom im Kopf-Hals-Bereich aus Serumproben
36. Investigation of the KIR-status of patients with head and neck squamous-cell carcinoma in bloodserum
37. Autoantibodies against SUMO1-DHX35 in long-COVID
38. Preclinical Evaluation of a New ECCO2R Setup
39. Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients
40. Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells.
41. Cost‑effectiveness of precision cancer medicine‑current challenges in the use of next generation sequencing for comprehensive tumour genomic profiling and the role of clinical utility frameworks (Review)
42. IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study
43. Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial
44. Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas
45. Autoantibodies against Progranulin and IL-1 receptor antagonist due to immunogenic posttranslational isoforms contribute to hyperinflammation in critically ill COVID-19
46. Autoantibodies against IL-1-receptor-antagonist in multisystem inflammatory syndrome in children
47. Preclinical Evaluation of a New ECCO 2 R Setup.
48. Konjunktivales Mantelzelllymphom – eine therapeutische Herausforderung
49. The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma Cells
50. Additional file 1 of Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.